Skip to main content

European cell therapy in the nervous system

Objective

Ectins will find commercially viable ways to derive conditionally immortalised neural stem cells, identify their key phenotype features, patterns of gene expression and biological activities that predict in vivo efficacy. We shall demonstrate clinical potential, study dosing and cell placement through developing predictive animal models of human neurological disease states. Media formulations will be optimised for long term viability, maintain efficacious properties and minimise toxicity. We shall develop non-invasive magnetic resonance imaging methods to follow the activity of grafted cells in human stroke patients. Scientific innovation at all stages of the programme will ensure future product pipelines.

Funding Scheme

CSC - Cost-sharing contracts

Coordinator

RENEURON LIMITED
Address
5-11 Lavington Street
SE1 0NZ London
United Kingdom

Participants (8)

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR - ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO
Italy
Address
Via Olgettina 58
20132 Milano
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France
Address
Rue De Tolbiac, 101
75654 Paris
KING'S COLLEGE LONDON
United Kingdom
Address
De Crespigny Park, Denmark Hill
SE5 8AF London
LUDWIG INSTITUTE FOR CANCER RESEARCH
United Kingdom
Address
Riding House Street 91
W1W 7BS London
MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.
Germany
Address
18 A,am Klopferspitz 18 A
82152 Planegg-martinsried
MEDI-CULT A/S
Denmark
Address
Mollehaven 12
4040 Jyllinge
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
United Kingdom
Address
Trinity Lane, The Old Schools,
CB2 1TN Cambridge
UNIVERSITY OF HELSINKI
Finland
Address
Yliopistonkatu 4
00014 Helsinki